CardiocomŪ Announces Telehealth Launch in Europe to Meet Demand for Chronic Disease Management Products |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Cardiocom LLC
7980 Century Blvd
Chanhassen, MN, 55317
USA
Press release date: May 14, 2007
MINNEAPOLIS, May 14 /-- CardiocomŪ, LLC, an industry leading developer and manufacturer of remote patient monitoring equipment and disease management software, announced that the company has obtained the required CE marking and certification and launched its products in the European market. CardiocomŪ has formed several distribution relationships in the United Kingdom where the U.K. government is providing significant funding for telehealth solutions to meet the needs of an aging population. The announcement will be made by Daniel Cosentino, President of Cardiocom, at the 2007 American Telemedicine Association (ATA) conference in Nashville, Tennessee.
"I am very pleased that we have found the right partnerships to bring our innovative technology to patients who will benefit from being connected every day to their health care team to manage their chronic disease and improve compliance," Cosentino emphasized. "Our distribution partners bring many years of experience as leading providers of telehealth, health care and social services in their communities. They share Cardiocom'sŪ passion for the highest quality medical technology and outstanding patient and customer service."
Cardiocom solutions are more than just biometric monitoring devices. The company has used its many years of telehealth experience to create an entirely new value in disease management by developing flexible intervention and management processes that are more efficient and more effective. The telehealth products and services operate as an integrated system for each specific disease state, offering clients maximum ability for complete management of patients with high risk conditions.
CardiocomŪ will provide its partners with the Commander, Commander Cellular and AutoLink(TM) monitoring and alert products, which are exclusively developed, manufactured and serviced by CardiocomŪ. The company's GlucoCom(TM) division will also supply blood glucose monitoring supplies for diabetic patients.
In addition to distributing products, Cardiocom'sŪ United Kingdom partners will provide nurse call center services for daily monitoring of patient biometric data, health status and compliance. The nurses will use Cardiocom'sŪ comprehensive web-based OmniVisor Pro(TM) patient management software system. This highly intelligent system increases nurse efficiency by at least double traditional case ratios and improves clinical effectiveness by promoting daily patient engagement, behavior change and self-management.
With the European launch, CardiocomŪ is positioning itself to provide additional unique and extremely focused telemonitoring enhancements to meet the growing international demand for services to help aging populations stay connected with their health care professionals while remaining independent in their homes for a longer time.
About Cardiocom LLC Cardiocom (http://www.cardiocom.com/) is an award-winning leader in innovative patient telemonitoring and disease management solutions. Founded in 1997, Cardiocom develops, manufactures and markets its own telehealth devices for congestive heart failure, diabetes, hypertension, obesity, COPD, severe asthma, and ESRD. GlucoCom(TM) (http://www.glucocom.com/), a division of Cardiocom offering blood glucose monitoring products, was added to the product line in 2006. Cardiocom's clients include some of the most respected health plans, hospitals, physician groups, home health groups and disease management vendors in the nation. Through these established relationships, Cardiocom improves the lives of thousands of people each day.
Contact: Jodie Root, Vice President, Sales & Marketing, Cardiocom 888-243-8881 or jroot@cardiocom.com
Source: Cardiocom, LLC
Web site: http://www.cardiocom.net/ http://www.glucocom.com/
|
|
|
|
|
|
|
|
|
|
|
| 
